Covid-19 Diary : Sunday 31 May, 2020
It is nice to be properly back after yesterday’s 12 hour power cut. So lots of stuff, below. What a curious few days it has been. The good news – almost exactly nine …
It is nice to be properly back after yesterday’s 12 hour power cut. So lots of stuff, below. What a curious few days it has been. The good news – almost exactly nine …
A power cut at lunchtime lasted 12 hours (originally promised to be only two hours) and so I was unable to send out a normal diary entry for Saturday. Although there have been some …
Have you noticed the latest buzzword that is being used everywhere? “Epicenter” (or, for our very good friends elsewhere, “epicentre”). Originally used to refer to the point on the earth’s surface vertically above the …
Yesterday’s new version of the “facts and figures” table showed some opportunities for improvement. I’ve reformatted it for today, let’s see what it looks like, and we’ll continue to adapt, adopt, and improve as …
I am writing this from The Travel Insider world headquarters (ie my basement) while being very conscious that if things were slightly different, I’d be in Bordeaux today with a happy group of Travel Insiders, …
Should You – Can You – Travel to Europe This Summer? Read More »
It is a lovely day here today. Many people have rushed to claim that the virus will be harmed by good weather. There is however absolutely no data to support that claim, just wishful …
Today saw us cross another milestone (probably not a good term – it implies progress) on the Covid-19 road. The US passed the 100,000 mark for virus-related fatalities this morning. Depending on your world-view, …
Here’s a good article that summarizes two thoughts I keep coming back to. The first is our response, in the US, to the coronavirus threat is being handicapped by politics and by political correctness. …
The stock market was very enthusiastic about the news last week of early positive results with the current vaccine candidate being developed by Moderna. The only thing is, the “news” was a press release …
The more detailed results of the controversial remdesivir study have now been published. It seems like a fairly clean and clear analysis. There are no real surprises in it, compared to the earlier summaries. …
A new hydroxychloroquine study was published in the British journal “The Lancet” today. On the face of it, it appears to be an excellent study. It has a very large number of patients (96,032) …
I started off with an opening commentary on social distancing and the six foot “rule”; but decided it was sufficiently important to have its own article, and you’ve probably now already seen it. So …